共 12 条
[1]
Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anemias without hypoplastic bone marrow. Jonaova A,Neuwirtova R,Cermak J,et al. Britain Journal of Hematology . 1998
[2]
Feasibility of peripheral blood progenitor cell harvest and transplantation in patients with poor-risk myelodysplastic syndromes. Demuynck H,Delforge M,Verhelf GEG,et al. Britain Journal of Hematology . 1996
[3]
A randomized control trial of subcutaneous azacytidine in patients with the myelodysplastic syndromes: a study of the cancer and Leukemia group B. Silverman LR,Demakos EP,Peterson B,et al. Proceedings of the American Society of Clinical Oncology . 1998
[4]
Randomized phaseⅡstudy of rGM-CSF in patients with neutropenia secondary to myelodysplastic syndromes. Shuter MW,Thompson JA,Larson B,et al. Blood . 1995
[5]
Hematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary AML: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Dewitte T,Hermans J,Vossen J,et al. Britain Journal of Hematology . 2000
[6]
Low dose melphalan induces favourable response in elderly patients with high risk myelodysplastic syndromes or secondary leukemia. Denzlinger C,Benz D,Bowen D,et al. Britain Journal of Hematology . 2000
[7]
A predictive model for the clinical response to low dose ara-C: a study of 102 patients with myelodysplastic syndromes or acute leukemia. Hellstrom LE,Robert KH,Gahrton G,et al. Britain Journal of Hematology . 1992
[8]
Leukemia[P]. 英国专利:GB0221802D0,2002-10-30
[9]
All trans retinoic acid with low dose cytosine arabinoside in the treatment of myelodysplastic syndrome. Nair R,Nair CN,Advani SH. Leukemia and Lymphoma . 1998
[10]
Results of topotecan-based combination therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Beran M,Kantarjian H. Seminars in Hematology . 1999